Baxter InternationalWBO:BAX +3.29%55 OCF Margin % is 7.89% as of Mar. 2026, which is 51% below its 10-year median of 16.23. GuruFocus rates WBO:BAX with a GF Score™ of 55/100 and a GF Value™ of €28.97 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Baxter International ranks better than 59.88% on this metric.
The historical rank and industry rank for Baxter International's OCF Margin % or its related term are showing as below:
WBO:BAX'
s OCF Margin % Range Over the Past 10 Years
Min: 7.52 Med: 16.23 Max: 18.52
Current: 11.03
During the past 13 years, the highest OCF Margin % of Baxter International was 18.52%. The lowest was 7.52%. And the median was 16.23%.
WBO:BAX's OCF Margin % is ranked better than 59.88% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs WBO:BAX: 11.03
Baxter International OCF Margin % Related Terms
Baxter International OCF Margin % Historical Data
* Premium members only.
The historical data trend for Baxter International's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:BAX vs COO, ATR, RGEN: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Baxter International's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baxter International OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Baxter International's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Baxter International's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baxter International (WBO:BAX) has a OCF Margin % of 7.89% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Baxter International and its competitors. This is 51% below median its historical median of 16.23. Over the past decade, Baxter International's OCF Margin % has ranged from 7.52 to 18.52. According to the industry distribution chart, Baxter International ranks #327 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 40.1%.
Is Baxter International's OCF Margin % too high?
Baxter International's current OCF Margin % of 7.89% is 51% below median its 10-year median of 16.23. Over the past 10 years, this metric has ranged from a low of 7.52 to a high of 18.52. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Baxter International's value of 7.89% is 34.6% above this industry median. Based on the distribution chart, Baxter International ranks #327 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Baxter International has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Baxter International's OCF Margin % compare to COO and ATR?
According to the Medical Devices & Instruments industry distribution chart, Baxter International ranks #327 out of 815 companies for OCF Margin %. This puts Baxter International in the upper half of its industry. The industry median OCF Margin % is 5.86. Baxter International's value of 7.89% is 34.6% above this benchmark. Historically, Baxter International's own OCF Margin % has ranged from 7.52 to 18.52 over the past decade. While the company's 10-year median is 16.23 vs. the industry median of 5.86, Baxter International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baxter International's current OCF Margin % of 7.89% is 34.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Baxter International and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baxter International's current OCF Margin % is 7.89%, which is 51% below median its own 10-year median of 16.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baxter International stock overvalued right now?
Based on GuruFocus' analysis, Baxter International (WBO:BAX) is currently considered Possible Value Trap. The stock's GF Value™ is €28.97, compared to a current price of €18.98 — trading 34.5% below its estimated fair value. The current OCF Margin % is 7.89%, which is 51% below median its 10-year median of 16.23 and 34.6% above the Medical Devices & Instruments industry median of 5.86. Baxter International's overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Baxter International (WBO:BAX), the current OCF Margin % is 7.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baxter International (WBO:BAX) Overvalued in 2026?
Based on GuruFocus' analysis, Baxter International stock appears to be undervalued.
The current stock price of €18.98 is trading 34.5% below its estimated GF Value™ of €28.97.
GuruFocus considers Baxter International to be Possible Value Trap.
Key valuation signals for WBO:BAX:
OCF Margin %: 7.89% (51% below median its 10-year median of 16.23)
GF Value™: €28.97 vs. price of €18.98 (34.5% below fair value)
Industry Position: 34.6% above the Medical Devices & Instruments median (#327 of 815)
No single metric tells the full story. See the WBO:BAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
55GF Score
Get the complete analysis for WBO:BAX
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:BAX has been successfully added to your 
